(MRDDF) Director Resigns

Miranda Gold Corp. (“Miranda”) (TSX-V: MAD) reports that Steve Ristorcelli, has resigned as a director of Miranda. He has served as a non-executive independent director for the past 19 years.

“We appreciate the contribution Steve has made in serving as a director for Miranda, providing the board with additional technical support and oversight to Miranda” said Board Chairman and CEO, Ken Cunningham.

The Company has four remaining directors two of whom are independent. The Company intends to recruit a third independent director.

About Miranda

Miranda is a gold exploration company active in Nevada, Alaska and Colombia, whose emphasis is on generating gold exploration projects with world-class discovery potential. Miranda performs its own grass roots exploration and then employs a joint venture business model on its projects in order to maximize exposure to discovery while minimizing exploration risk. Miranda has ongoing relationships with Agnico Eagle Mines Ltd., Prism Resources, Montezuma Mines Inc., and Red Eagle Mining Corporation.

For more information related to Miranda: Joe Hebert, Executive Vice President 775-738-1877
www.mirandagold.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

(MINE) VitaminFIZZ® Begins 2nd Production Run Ahead of Schedule

Minerco’s Level 5 to Have Black Raspberry, Strawberry Lemonade and Pineapple Coconut on Shelves in September

HOUSTON, Sept. 11, 2014  — Level 5 Beverage Company, Inc., a subsidiary of Minerco Resources, Inc. (OTCQB:MINE), begins the second production run of its functional sparkling waters, VitaminFIZZ® today. This production run includes three new VitaminFIZZ flavors: Black Raspberry, Strawberry Lemonade and Pineapple Coconut. Level 5 Beverage will be producing the three new flavors this run to deliver to retail outlets in New York and Southern California. Bottles will also be made available for purchase on Amazon.com.

“The response to VitaminFIZZ has been extremely positive,” said V. Scott Vanis, Minerco’s Chairman and CEO. “In fact, the response has been so robust that we have begun production on our three new flavors ahead of schedule. While we focus our efforts on NYC and Southern California, we see this as a good sign for upcoming rollouts into new markets.”

This second run comes after a successful initial launch of VitaminFIZZ in August that included distribution to New York and Southern California through distributors Drink King and Avanzar, respectively. The initial launch of VitaminFIZZ also included sales through Amazon.com. Approximately 10,000 cases of VitaminFIZZ have been sold (including Purchase Orders) in just the first 20 days. The first run of VitaminFIZZ in August produced over 15,000 cases in the three original flavors, Orange Mango, Strawberry Watermelon and Lemon Lime.

All VitaminFIZZ flavors offer 100% of the Recommended Daily Intake of Vitamin C, Vitamin B6 and Vitamin B12. VitaminFIZZ fans should expect to see the new flavors available in late September on shelves in the New York market, closely followed by California and online at Amazon.com.

“Our distribution paths are opening up faster than anticipated,” said Darin Ezra, CEO of Power Brands Consulting and Director of Level 5 Beverage. “Retailers and distributors alike are quickly finding value in the VitaminFIZZ brand and with this momentum, we expect to see strong penetration in the first two markets before the end of the year.”

About VitaminFIZZ®

VitaminFIZZ is a lightly sparkling, flavor-filled, refreshing beverage with an awesome boost of essential vitamins developed to quench your thirst, naturally. VitaminFIZZ is caffeine free, is Non GMO, has zero calories and contains 100% of recommended daily Vitamin B and Vitamin C. Awaken your taste buds. Now that’s refreshing. See more at: www.vitamin-fizz.com, www.twitter.com/vitaminfizz and www.facebook.com/drinkvitaminfizz.

About Minerco Resources, Inc.

Minerco Resources, Inc. (OTCQB:MINE), is the parent company of Level 5 Beverage Company, Inc. (Level 5), a specialty beverage company which develops, produces, markets and distributes a diversified portfolio of forward-thinking, good-for-you consumer brands. The Level 5 brand umbrella includes: VitaminFIZZ(R), Vitamin Creamer(R), Coffee Boost(TM), The Herbal Collection(TM) and LEVEL 5(R). http://minercoresources.com.

Public Disclosure

Details of the Company’s business, finances and agreements can be found as part of the Company’s continuous public disclosure as a fully reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission’s (“SEC”) EDGAR database. For more information, please visit: http://www.minercoresources.com. The above statements have not been evaluated by the Food and Drug Administration (FDA). These products are not intended to diagnose, treat, cure or prevent any disease.

Safe Harbor Statement

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934 that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations and assumptions upon which they are based are reasonable, we can give no assurance that such expectations and assumptions will prove to have been correct. Some of these uncertainties include, without limitation, the company’s ability to perform under existing contracts or to procure future contracts. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including without limitation, successful implementation of our business strategy and competition, any of which may cause actual results to differ materially from those described in the statements. We undertake no obligation and do not intend to update, revise or otherwise publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of any unanticipated events. Although we believe that our expectations are based on reasonable assumptions, we can give no assurance that our expectations will materialize. Many factors could cause actual results to differ materially from our forward-looking statements.

CONTACT: Jason Grimley
         Spelling Communications
         jasongrimley@spellcom.com
         323-309-8714

(BSRC) Teams With UCSB to Develop a Low Cost Supercapacitor for Solar Energy Storage

Nobel Laureate Leads the Research Team Developing the Company’s BioSuperCap(TM), a Patent-Pending Bio-Inspired Supercapacitor That Will Be Lower Cost and Higher Energy Than Conventional Supercapacitors

(APPG) Acquires Mobile App Concept to Empower Local Active Sports Enthusiasts

(EFOI) Receives the Single Largest Order in the Company’s History

SOLON, Ohio, Sept. 11, 2014  — Energy Focus, Inc. (Nasdaq:EFOI), a leader in LED lighting technologies, today announced that the Company has received a $7.7 million order for the United States Navy combatant ship forces. This order, most of which is expected to be delivered throughout the remainder of 2014, represents the single largest order in the Company’s history.

This new delivery order is entirely for Energy Focus’ Intellitube® LED retrofit tubes. This true plug and play technology allows for direct fit into existing fluorescent sockets with or without the ballast in place. The proprietary circuit and LED lamp designed by Energy Focus is now employed and installed in more than 140 naval vessels in the vast U.S. Navy military fleet, up from fewer than 20 in the beginning of 2014.

“Over the past year, we have built extensive relationships with the U.S. Navy at various levels from the Pentagon to the ship forces, which now are broadly aware of the economic and sustainability benefits of our LED technologies, as well as the availability of our LED products,” said Eric Hilliard, President and Chief Operating Officer of Energy Focus. “We are extremely excited about and grateful for the unwavering commitment to energy and maintenance savings, as well as carbon reductions made by the leadership in the U.S. Navy. We are equally committed to working with and supporting all constituencies from the Navy to expedite their LED adoption initiatives in the quarters and years to come.”

“We are absolutely honored with the confidence the U.S. Navy has placed in Energy Focus and our LED products,” said James Tu, Executive Chairman and Chief Executive Officer of Energy Focus. “With over three decades of advanced lighting development experience and a long-term research partnership with the U.S. government in LED lighting since 2002, Energy Focus remains the only Navy Military-Spec qualified LED replacement lamp provider. We are also proud to say there has been zero failure in the lamps we have put on U.S. Navy ships since our first installation in 2007. We plan and fully expect to leverage our proven technologies and the resounding successes we have had with the U.S. Navy to build our presence and leadership in the broader maritime market, including military and non-military vessels that together represent a total addressable market of over $4 billion.”

Forward Looking Statements

Forward-looking statements in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Generally, these statements can be identified by the use of words such as “believes,” “estimates,” “anticipates,” “expects,” “seeks,” “projects,” “intends,” “plans,” “may,” “will,” “should,” “could,” “would” and similar expressions intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements include all matters that are not historical facts. By their nature, forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from Energy Focus’ forward-looking statements. These risks and uncertainties include, but are not limited to: the timing of the shipment of orders in our backlog, the benefits and performance of our lighting products; our ability to expand our sales with existing customers and other customers in the maritime market; growth in the markets into which Energy Focus sells; conditions of the lighting industry and the economy in general; statements as to our competitive position; the development and marketing of new products; relationships with the U.S. Navy, customers and distributors; trends in the price and performance of light-emitting diode (“LED”) lighting products; and our strategy with regard to protecting our proprietary technology. For more information about potential factors that could affect the financial results of Energy Focus, please refer to the Company’s SEC reports, including its Annual Reports on Form 10-K and its quarterly reports on Form 10-Q. These forward-looking statements speak only as of the date hereof. Energy Focus disclaims any intention or obligation to update or revise any forward-looking statements.

CONTACT: Media and Investor Contact:
         Energy Focus, Inc.
         (440) 715-1300
         pr@energyfocusinc.com
         ir@energyfocusinc.com

(PLKD) “Where Healthy Begins” Campaign, to Begin Distribution to 7-Eleven Franchises

BURBANK, Calif., Sept. 11, 2014  — NYBD Holding, Inc. (OTCPK: PLKD), Pleasant Kids Inc, America’s premium supplier of naturally balanced alkaline water and all natural apple juice for children is pleased to announce that the Company will begin distribution of Pleasant Kids products to 7-Eleven franchises in South Florida. The initial roll out will commence with Pleasant Kids Products being available in over 30 select 7-Eleven locations with additional stores being added on a regular basis.

“We are very proud to have this opportunity to offer Pleasant Kids products to 7-Eleven franchises, the largest and most recognizable convenience store brand in the world,” commented Robert Rico, CEO of Pleasant Kids Inc. “We are off to a great start and based on our success with these select franchise locations, we expect to continue to expand our distribution footprint to potentially include all 7-Eleven franchises. We intend to undertake a very deliberate yet methodical approach towards increasing the Pleasant Kids footprint globally and this is the type of relationship that can expedite those efforts. The framework for our goal of experiencing exponential quarter over quarter growth is being laid out and we expect those results to begin to take us to the next level.”

Whats Next…

There will be no reverse split of our shares for the upcoming quarter. The board of directors has elected that there will be no reorganization of the companies common share for 2014.

Pleasant Kids can be found on the shelves of Price Choice Grocers, Presidente Supermarkets, Diamond Mart, C and B Distributers, R C Distributers, ICSSF Public Charter Schools, 7 Eleven Stores in South Florida, and  online at www.pleasantkids.com and many more coming soon.

As always we would like to thank all of our shareholders and will continue to operate our company in a manner that best serves you. We will continue to update as to our accomplishments on a regular basis.

About 7 Eleven

7‑Eleven is the world’s largest convenience store chain with more than 53,500 stores in 16 countries, of which close to 10,400 are in North America. The company operates franchises and licenses close to 8,700 convenience stores in the U.S. and Canada. Of the more than 7,800 stores the company operates and franchises in the United States, more than 6,200 are franchised. Outside of the U.S. and Canada, there are more than 44,800 7‑Eleven and other convenience stores in Japan, Taiwan, Thailand, South Korea, China, Malaysia, Mexico, Singapore, Australia, Philippines, Indonesia, Norway, Sweden and Denmark. In 2012, 7 Eleven Stores generated worldwide sales in excess of  84 Billion Dollars.

About Pleasant Kids Inc.

Headquartered in Burbank, CA. Pleasant Kids is America’s premium supplier of naturally balanced pH-8.0+spring(alkaline) “healthy water” for children. The company features copyrighted mascot characters. The brand focuses on a positive message of love, happiness, and joy for children of all ages. Additionally, all the products are eco-friendly, BPA free, Non-toxic, No Bisphenol A, and No Phthalates. Pleasant Kids, Inc. owns and operates Pleasant Kids EXTRA, Inc. EXTRA manages the intellectual copyrighted characters and makes them available for select and limited business development, sponsorship opportunities and licensing deals

Safe Harbor Statement

THIS NEWS RELEASE CONTAINS “FORWARD-LOOKING STATEMENTS”, AS THAT TERM IS DEFINED IN SECTION 27A OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, AND SECTION 21E OF THE UNITED STATES SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. STATEMENTS IN THIS NEWS RELEASE, WHICH ARE NOT PURELY HISTORICAL, ARE FORWARD-LOOKING STATEMENTS AND INCLUDE ANY STATEMENTS REGARDING BELIEFS, PLANS, EXPECTATIONS OR INTENTIONS REGARDING THE FUTURE. EXCEPT FOR THE HISTORICAL INFORMATION PRESENTED HEREIN, MATTERS DISCUSSED IN THIS NEWS RELEASE CONTAIN FORWARD-LOOKING STATEMENTS THAT ARE SUBJECT TO CERTAIN RISKS AND UNCERTAINTIES THAT COULD CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM ANY FUTURE RESULTS, PERFORMANCE OR ACHIEVEMENTS EXPRESSED OR IMPLIED BY SUCH STATEMENTS.STATEMENTS THAT ARE NOT HISTORICAL FACTS, INCLUDING STATEMENTS THAT ARE PRECEDED BY, FOLLOWED BY, OR THAT INCLUDE SUCH WORDS AS”ESTIMATE”, “ANTICIPATE”, “BELIEVE”, “PLAN” OR “EXPECT” OR SIMILAR STATEMENTS ARE FORWARD-LOOKING STATEMENTS. FORWARD-LOOKING STATEMENTS CONTAINED IN THIS NEWS RELEASE INCLUDE STATEMENTS RELATING TO AS WELL AS THE RISKS SHOWN IN THE COMPANY’S MOST RECENT ANNUAL AND QUARTERLY REPORTS ON FORM 10-K AND FORM 10-Q, RESPECTIVELY, AND FROM TIME-TO-TIME IN OTHER PUBLICLY AVAILABLE INFORMATION REGARDING THE COMPANY. OTHER RISKS INCLUDE RISKS ASSOCIATED WITH THE REGULATORY APPROVAL PROCESS, COMPETITIVE COMPANIES, FUTURE CAPITAL REQUIREMENTS AND THE COMPANY’S ABILITY AND LEVEL OF SUPPORT FOR ITS EXPLORATION AND DEVELOPMENT ACTIVITIES. THERE CAN BE NO ASSURANCE THAT THE COMPANY’S EXPLORATION EFFORTS WILL SUCCEED AND THE COMPANY WILL ULTIMATELY ACHIEVE COMMERCIAL SUCCESS. THESE FORWARD-LOOKING STATEMENTS ARE MADE AS OF THE DATE OF THIS NEWS RELEASE, AND THE COMPANY ASSUMES NO OBLIGATION TO UPDATE THE FORWARD-LOOKING STATEMENTS, OR TO UPDATE THE REASONS WHY ACTUAL RESULTS COULD DIFFER FROM THOSE PROJECTED IN THE FORWARD-LOOKING STATEMENTS. ALTHOUGH THE COMPANY BELIEVES THAT THE BELIEFS, PLANS, EXPECTATIONS AND INTENTIONS CONTAINED IN THIS NEWS RELEASE ARE REASONABLE, THERE CAN BE NO ASSURANCE THOSE BELIEFS, PLANS, EXPECTATIONS OR INTENTIONS WILL PROVE TO BE ACCURATE. INVESTORS SHOULD CONSIDER ALL OF THE INFORMATION SET FORTH HEREIN AND SHOULD ALSO REFER TO THE RISK FACTORS DISCLOSED IN THE COMPANY’S PERIODIC REPORTS FILED FROM TIME-TO-TIME WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION. THIS NEWS RELEASE HAS BEEN PREPARED BY MANAGEMENT OF THE COMPANY WHO TAKES FULL RESPONSIBILITY FOR ITS CONTENTS. NO SECURITIES REGULATORY AUTHORITY HAS APPROVED OR DISAPPROVED OF THE CONTENTS OF THIS NEWS RELEASE. THIS NEWS RELEASE SHALL NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY NOR SHALL THERE BE ANY SALE OF THESE SECURITIES IN ANY JURISDICTION IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL PRIOR TO REGISTRATION OR QUALIFICATION UNDER THE SECURITIES LAWS OF ANY SUCH JURISDICTION.

For more information and all the latest from Pleasant Kids, Inc. (PLKD)
Please contact customer service at +1-855-710-KIDS or visit us at www.pleasantkids.com
Email us at info@pleasantkids.com
Pleasant Kids, Inc. 2600 West Olive, 5F Burbank, CA 91505

(VNRX) NuQ® Blood Test Detects 84% of Colorectal Cancers, Incl. Early & Late Stage

Topline Data from 1,000-Subject Independent Blinded Trial to be Presented 9am PT Today during Aegis Capital 2014 Healthcare & Technology Conference; webcast at volitionrx.com

NAMUR, Belgium, Sept. 11, 2014  — VolitionRx Limited (OTCQB: VNRX), a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types, today announced that CEO Cameron Reynolds will this morning present topline data from its 4,800-subject colorectal cancer trial at Hvidovre Hospital, Copenhagen, Denmark. Mr. Reynolds will present data from an initial representative 938-subject sample, demonstrating that the Company is able to correctly diagnose 84% of colorectal cancers, including early-stage cancers, using its NuQ® blood-based diagnostic platform.

Mr. Reynolds will discuss the data during a presentation at the 2014 Aegis Capital Healthcare & Technology Conference today at 9:00 a.m. U.S. Pacific Time. Mr. Reynolds’ presentation will be available from today on the Company’s website at www.volitionrx.com.

Despite the existence of screening programs for the disease, colorectal cancer remains the second leading cause of cancer-related death in the U.S.[i], partly due to the cost, and to low compliance with colonoscopies and other screening methods like fecal tests. Furthermore, colorectal cancer is often found after symptoms appear, which typically only happens with more advanced disease[i]. However, colorectal cancer is one of the more survivable diseases if caught early: it has an observed five-year survival rate of 74% in stage I, but only 6% in stage IV[i]. Put simply, many lives could be saved if colorectal cancer were caught earlier. VolitionRx’s NuQ® test aims to meet this need by detecting colorectal cancer through a simple, accurate, cost-effective, blood test.

Analysis of the 938-subject sample of the study demonstrated that the NuQ® diagnostic test detected 84 percent of colorectal cancers at 78% specificity, and 60 percent of polyps, in a population aged over 50 years with symptoms indicative of colorectal cancer. The NuQ® test used to achieve these results was a panel of three individual NuQ® assays, each of which identifies and measures a separate nucleosome structure in the blood. Each NuQ® panel used a small amount of blood – only 60µL or about a drop per subject. Data showed that the NuQ® test is able to detect early stage (I or II) disease and late-stage (III or IV) disease with similar accuracy, allowing for earlier detection and treatment of colorectal cancer and enabling the potential for improved patient outcomes.

Dr. Jake Micallef, Chief Scientific Officer of VolitionRx, commented, “VolitionRx has shown similar results previously in smaller colorectal cancer studies but confirmation that NuQ® tests are effective in a large, blind study is a landmark result for us. Moreover, the Nucleosomics® technology is not limited to the three assays used in this study, but incorporates hundreds of potential epigenetic NuQ® tests that may have applicability in colorectal and other cancers. We will share further analysis of the results from these 938 subjects at the 9th International Conference of Anticancer Research in October this year.”

Professor Hans Jorgen Nielsen, Professor of Surgical Oncology at Hvidovre Hospital in Denmark, remarked, “This is an extremely promising result in a symptomatic population. Collection has now begun for a much larger 14,000-subject screening study in Denmark, and we expect to begin delivering the first several thousand samples to VolitionRx for analysis in the early part of 2015.”

Cameron Reynolds, Chief Executive Officer of VolitionRx Limited, commented, “An accurate, early, and cost effective blood test to screen for colorectal cancer would mark a revolutionary advancement in the way we test for and diagnose this terrible disease. These exciting results from our latest analysis, which demonstrated 84% accuracy in colorectal cancer detection, confirm that the NuQ® test enables accurate early identification of colorectal cancer through a simple blood test.”

VolitionRx has today closed a fund raise of $1.127 million. The raise consists of 512,614 shares at $2.20 (including insider conversions of $46,748). Monies raised will go towards VolitionRx’s ongoing operations and clinical trials.

VolitionRx will host a conference call to discuss this data, raise and the Company’s ongoing strategy on Tuesday, September 16 at 10 a.m. US Eastern Time. To attend the call, please use the information below for dial-in access. When prompted on dial-in, please utilize the conference ID or ask for the “VolitionRx Limited Investor Conference Call.”

Please dial in at least 10 minutes before the call to ensure timely participation. A playback will be available through September 30, 2014. To listen, please call +1-877-870-5176 within the United States or +1-858-384-5517 if calling internationally. Utilize the pass code 64623766 for the replay.

About VolitionRx

VolitionRx is a life sciences company focused on developing blood-based diagnostic tests for different types of cancer. The tests are based on the science of Nucleosomics which is the practice of identifying and measuring nucleosomes in the bloodstream – an indication that cancer is present.

VolitionRx’s goal is to make the tests as common and simple to use, for both patients and doctors, as existing diabetic and cholesterol blood tests. VolitionRx’s research and development activities are currently centred in Belgium as the company focuses on bringing its diagnostic products to market first in Europe, then in the U.S. and ultimately, worldwide.

Visit VolitionRx’s website (www.volitionrx.com) or connect with us on Twitter, LinkedIn, Facebook or YouTube.

About the Trial

This representative blinded 938-subject sample (these results were CRC versus no findings on colonoscopy and no comorbidities) was drawn from a 4,800 symptomatic-subject study conducted at Hvidovre Hospital, Copenhagen, Denmark. Samples were collected from 2010 to 2012 from subjects with colorectal cancer, polyps or adenomas, benign bowel diseases or other malignancies, all of whom have undergone a colonoscopy. Under the trial design, VolitionRx has full anonymized access to all Danish national registries and databases. The study group were all aged over 50; results were age- and gender-adjusted.

Safe Harbor Statement

Statements in this press release may be “forward-looking statements”. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “optimizing,” “potential,” “goal,” and similar expressions, as they relate to the Company, its business or management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the Company’s business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in the Company’s filings with the Securities and Exchange Commission.

Media Contacts

Charlotte Reynolds, VolitionRx
Telephone: +44 (0) 795 217 7498
Email: Charlotte.Reynolds@volitionrx.com

Kirsten Thomas, The Ruth Group
kthomas@theruthgroup.com
Telephone: +1 (646) 536-7014

Investor Contacts

Scott Powell, VolitionRx
S.Powell@volitionrx.com
Telephone: +1 (917) 721-9480

Lee Roth, The Ruth Group
lroth@theruthgroup.com
Telephone: +1 (646) 536-7012

(FBCD) Receives Additional Purchase Order For 100,000 Compression Knee Sleeves

NEW YORK, NY, United States, via ETELIGIS INC., 09/10/2014 – – FBC Holding, Inc. (PINKSHEETS: FBCD) (FBC or the Company) an international product development company primarily focused on license/creation management and product sales/distribution through DRTV, announced that the company received an additional purchase order for 100,000 units for a compression knee sleeve.

Understanding that our goal was to utilize our contacts within the industry and build a product that would be successful, not only by the company but ultimately the consumer. Having delivered approximately 1.4 million compression knee sleeves to date and now receiving this additional 100,000 unit order, is very exciting for our company said Mr. Frank Russo, Chief Executive Officer of FBC Holding, Inc. To date the total retail value of all the orders have reached approximately $15 million and has been an extremely successful venture for our company in such a short period of time.

Having executed this project really opened our eyes, seeing that the marketplace is accepting of compression fabrics that have been infused with copper. With that said, we are not only exploring sports related support items but looking at products that are used in our everyday life stated Mr. Russo, One of our goals is to introduce an item or items that have value, serve a benefit for the consumer and drive revenue for the company. Margin is the key to a successful business model and our focus is on the $15 million program that has been delivered to date. We learned many valuable lessons during this process, most importantly controlling our own destiny in order to capitalize on our own ability to develop, manufacturer and deliver product under the Copper-Tech brand.

Having the ability to develop the fabric from the yarn level has provided our company with the following benefits: 1) Retention of copper in the yarn of 99.9% after 30 wash cycles, 2) Anti-Microbial properties that kill fungus, bacteria and have odor eliminating properties as well, 3) Kills approximately 70% of P-Acne and 4) Reduction of body heat by 30 degrees Fahrenheit over a 40 minute frame. With these benefits, we are now awaiting finished samples that will reflect the above mentioned benefits that we can review and potentially make changes to construction, confirming fit and sizing.

About FBC Interactive Division

FBC Holdings Interactive Division markets innovative products generally incorporating new proprietary technologies. FBC Interactive, leverages Direct Response Television (DRTV) formats to advertise, market and distribute its products; gaining retail footholds in various markets. FBC Interactives market place is diverse, with a primary focus and expertise in toy and entertainment, consumer and health care, products and brands.

About FBC Holding, Inc.

FBC Holdings develops and markets innovative products using a new proprietary technology whereby buttons, switches, wires and other electrical components can be printed on nearly any media. Management is experienced in Direct to Consumer Marketing (design, manufacture and market creative products leveraging cutting edge technology). FBCs market is diverse, covering consumer products, health care related products, and, toy and entertainment products.

Safe Harbor

This news release contains forward-looking statements. Forward-looking statements are statements which relate to future events. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors that may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggested herein. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results. Readers are referred to the sections entitled “Risk Factors” in the Company’s periodic filings with the United States Securities and Exchange Commission, which can be viewed at http://www.SEC.gov. For all details regarding working interests in all of FBC Holdings interest, and/or any previous news releases, go to OTC Markets website. You should independently investigate and fully understand all risks before making investment decisions.

Related Links:

http://finance.yahoo.com/news/fbc-holding-positioned-rapid-growth-142935672.html

http://finance.yahoo.com/news/fbc-interactives-direct-response-marketing-140000170.html

For Investor Relations,

FBC Holding, Inc.

info@fbcholdinginc.com

(TBEV) Completes $1.5 Million Dollar Private Placement

CAVE CREEK, AZ, United States, via ETELIGIS INC., 09/10/2014 – – High Performance Beverage Co. (OTC Pink: TBEV) (PINKSHEETS: TBEV) (the “Company”) is pleased to announce it has closed its $1.5 million dollar Private Placement financing.

The $1.5 million will come in the form of three separate tranches of $500,000 over the next several months as the company implements its core business model which will also include the introduction of additional beverage flavors and potential trend beverage mixtures throughout the year.

The Company still anticipates putting its Throwdown High Performance drink into full production for a dual coast distribution during the month of October 2014.

Toby McBride, High Performance Beverage Company CEO, stated, “We are very pleased to announce the closing of our Private Placement. We are currently awaiting the first initial $500,000 as we draw closer to putting Throwdown High Performance Beverages into full production. Distributors on both east and west coasts are prepared to put TBEVs product line on retailer shelves.

The Company is also pleased to announce it has completed the revamping of its Company website. Upon initial distribution of TBEVs product lines all beverages will be available for retail purchase on the website.

About High Performance Beverage Company

High Performance Beverage Company has created a new beverage segment, under the trade name, Throwdown Performance Beverages, which manufactures and distributes a line of sport performance beverages. High Performance Beverage Company’s sport performance drinks are carefully formulated to support mental focus and help increase blood flow, thereby giving the body the necessary fuel to power through a specific event or throughout the day. Our unique blends are designed to bridge the gap between supplements, energy and hydration drinks, ultimately broadening our appeal and providing access to an expanding target market. High Performance beverages are sugar free and extremely low in both calories and caffeine. This positioning makes High Performance Beverage Co. beverages first to market with a sustainable competitive advantage.

Safe Harbor

This release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of High Performance Beverage Company, its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words “may,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond High Performance Beverage Company’s ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. More information about the potential factors that could affect the business and financial results is and will be included in High Performance Beverage Company’s filings with the Securities and Exchange Commission.

High Performance Beverage Co.

Public Relations and Shareholder Information

Joseph M. Vazquez III

Phone: (800) 767-9396

Email: infinityglobalconsulting@gmail.com

(TEVE) HyperCaster 4K Broadcaster Awarded Four Diamonds by BTR

(NXHD) Next Slide the City™ Event: Los Angeles, California — September 28, 2014

(FRZT) Partners W/ HighWater Group to Launch ‘Party Animals: Dance Battle’

TUSTIN, Calif., Sept. 10, 2014 — Freeze Tag (OTC:FRZT), a leading creator of mobile social games, today announced that it has selected HighWater Group as its marketing and PR agency to support the launch of its anxiously awaited free-to-play mobile game, Party Animals: Dance Battle.

“The app space is incredibly competitive and you need a savvy, integrated program to gain lift above the competitive din,” said Craig Holland, CEO, for Freeze Tag, Inc. “HighWater Group has the proven expertise within the mobile sector to help us gain traction with players.”

The collaborative partnership pairs the creative and interactive vision of Freeze Tag with the marketing and publicity acumen of HighWater Group. The integrated team is supported by an advanced set of metrics able to maximize monetization and player enjoyment while minimizing game disruption.

Set for a world-wide launch next month across iOS and Android app stores, Party Animals: Dance Battle is a fast-paced, multiplayer action game where battles are done on the dance floor.

About Freeze Tag, Inc.

Freeze Tag, Inc. is a leading creator of mobile social games that are fun and engaging for all ages. Based on a free-to-play business model that has propelled games like Candy Crush Saga to worldwide success, we employ state-of-the-art data analytics and proprietary technology to dynamically optimize the gaming experience for revenue generation. Players can download and enjoy our games for free, or they can purchase virtual items and additional features within the game to increase the fun factor. Our games encourage players to compete and engage with their friends on major social networks such as Facebook and Twitter. Founded by gaming industry veterans, Freeze Tag has launched several successful mobile games including the number one hit series Victorian Mysteries® and Unsolved Mystery Club®, as well as digital entertainment like Etch A Sketch®. Freeze Tag games have been downloaded millions of times on the Apple, Amazon and Google app stores.

Safe Harbor Notice

Certain statements contained herein are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). Freeze Tag, Inc. cautions that statements made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates and assumptions made by management. Actual results could differ materially from current projections or implied results. Freeze Tag, Inc. undertakes no obligation to revise these statements following the date of this news release.

CONTACT: info@freezetag.com
         714-210-3850 x26

(FLRE) Begins Shipping Cannadol Hemp Oil Orders

Company Plans on Introducing Second CBD (“Cannabidiol”) Product Within Days Company to Open Amazon Webstore to Further Drive Online Revenues

VENICE, Fla., Sept. 10, 2014  — Flameret, Inc. (OTC: FLRE) announced today that Royal Hemp Corporation, its wholly-owned Colorado subsidiary, has begun shipping high CBD hemp oil orders. The company previously announced the launch of Cannadol™, its high CBD (cannabidiol) hemp oil. Over the first three days after the product launch was announced, the company received orders from 21 different customers. Further details regarding initial revenues will be announced in the company’s financial statements that will be filed at http://www.otcmarkets.com.

Cannadol™ is a dietary supplement sold as a hemp oil rich in CBD. It consists of 200mg of cannabidiol cold pressed from industrial hemp in an oral suspension of 1 ounce of hemp oil. None of the statements regarding Cannadol™ or the potential therapeutic benefits of cannabidiol have been evaluated by the FDA.

Scientific and clinical studies continue to underscore CBD’s potential as a possible treatment for a wide range of conditions, including rheumatoid arthritis, diabetes, alcoholism, MS, chronic pain, schizophrenia, PTSD, antibiotic-resistant infections, epilepsy, and other neurological disorders. CBD has demonstrated neuroprotective and neurogenic capabilities, and its anti-cancer properties are currently being investigated at several academic research centers in the United States and elsewhere.

John Meredith, Chief Executive Officer of Flameret, Inc. remarked, “The launch of Cannadol™ and the response from consumers has far surpassed our internal expectations. We expect to deliver more good news to the investment public within a week.”

Mr. Meredith added, “It is very important as we update investors on our progress that investors also understand that we fully intend on pursuing what we perceive to be a large business opportunity in the flame retardant industry. There seems to be a misconception that we have abandoned that pursuit, however, nothing can be further from the truth. We have recognized an opportunity and we also had confidence that we can get a hemp-based product out on the market quickly. We have done that and our pursuit of a major business opportunity in the flame retardant industry continues.”

About Flameret

Flameret, Inc. has developed fire retardant products to suit a wide range of applications. These products are marketed under the brand names; Flameret, Flamex, Ultra Flamex and Impex. Flameret™ products are patented and held in the name of United American Inc.

The company is also in the process of launching a new line of products derived from industrial hemp which will be marketed and sold through Royal Hemp Corporation.

About Royal Hemp Corporation

Royal Hemp Corporation is a Colorado corporation which was created to market and sell hemp-based nutraceuticals, industrial products and consumer goods in the United States and throughout the world. All of the corporation’s products will be legal to sell in all states in the United States and in many countries throughout the world.

The press release may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to the Company’s development program and any other statements that are not historical facts. Such statements involve risks and uncertainties, including, but not limited to, those risks and uncertainties relating to difficulties or delays in development, testing, regulatory approval, production and marketing of the Company’s products, the uncertainty of patent protection for the Company’s intellectual property or trade secrets, and the Company’s ability to obtain additional financing. Such statements are based on management’s current expectations, but actual results may differ materially due to various factors, including those risks and uncertainties mentioned or referred to in this press release.

Contact: John Meredith: jwsmeredith@aol.com
+44 1732 460224

(AKER) $864,000 Sales Contract for Its Rapid Results Point of Care Cholesterol Test

New Cholesterol Test Takes Only Three Minutes to Produce Results; Addresses a Worldwide Market Estimated at $2 Billion

THOROFARE, N.J., Sept. 9, 2014  — Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the “Company” or “ABI”), a leading designer and manufacturer of rapid diagnostic screening and testing products, announced a contract valued at $864,000 for sales of its innovative Tri-Cholesterol “Check” tests in Australia, Singapore, the United Arab Emirates and Oman. The Company’s products are being distributed in such regions by 36 Strategies General Trading LLC (“36S”), a Dubai-based procurement solutions company. Target customers in Australia, Singapore, the United Arab Emirates and Oman include military forces, medical associations, universities and large companies operating in the resources sector.

The Company’s Tri-Cholesterol “Check” is a revolutionary finger-stick blood sample technology and the only combined rapid test which provides an estimate of both Total and High Density Lipoprotein (“HDL”) cholesterol levels;  thereby providing an estimate of the subject’s Low Density Lipoprotein (“LDL”) levels.

ABI’s Tri-Cholesterol “Check” test carries a U.S. Food and Drug Administration (“FDA”) Over-the-Counter approval; three CE marks for the European Economic Area; and a Health Canada approval.

Raymond F. Akers Jr., Ph.D, Executive Chairman of Akers Biosciences, stated, “This order gives us confidence that this test could become a very important and widely used test worldwide. There are an estimated 200 million people worldwide who have abnormal cholesterol levels. Our self-administered point-of-care test for cholesterol is easy-to-use, low cost, and revolutionary in point-of-care diagnostics. We are very pleased with the sales results we have achieved in these regions in a very short time through our distribution partner in the Middle East.”

Revenue related to this order for Tri-Cholesterol “Check” tests (a Rapid Enzymatic Assay product) was recognized in the accounts for the six months ended June 30, 2014.

ABOUT AKERS BIOSCIENCES, INC.

Akers Biosciences develops, manufactures, and supplies rapid, point of care screening and testing products designed to bring healthcare information both rapidly and directly to the consumer or healthcare provider. The Company has advanced the science of diagnostics while responding to major shifts in healthcare through the development of several proprietary platform technologies. The Company’s state-of-the-art rapid diagnostic assays can be performed virtually anywhere in minutes when time is of the essence. The Company has aligned with major healthcare companies and high volume medical products distributors to maximize product offerings, and to be a major worldwide competitor in diagnostics.

Additional information on the Company and its products can be found on our website at www.akersbiosciences.com. Follow us on Twitter @AkersBio.

Cautionary Statement Regarding Forward Looking Statements

Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target”, “intend” and “expect” and similar expressions, as they relate to Akers Biosciences, Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.

CONTACT: For more information:

         Raymond F. Akers, Jr. PhD
         Executive Chairman of the Board
         Akers Biosciences, Inc.
         Tel: +1 856 848 8698

         Brendan Hopkins
         RedChip Companies, Inc. (US Investor Relations)
         Tel: +1 407 644 4256 x134

         finnCap (UK Nominated Adviser and Broker)
         Geoff Nash / Scott Mathieson (Corporate Finance)
         Steve Norcross (Broking)
         Tel: +44 (0)20 7220 0500

         Ben Simons / Alexandra Roper
         Vigo Communications (UK Investor Relations)
         Tel: +44 (0)20 7016 9570
         akers@vigocomms.com

(MNTR) and Cannabis Edibles on Cover of Food & Drink

Marijuana Infused Products are Explained in First Full Length Cannabis Article by Thought Leading International Food Magazine

Mentor Capital, Inc. (OTC Markets: MNTR) announced it is pleased to be on the cover and featured in the “Budding Opportunities” Fall 2014 edition of Food & Drink which explores the “emerging world of cannabis edibles.” Over a range of topics and in plain terms, the article explains how and how much heating of marijuana by smoking or baking activates the psychoactive THC. This gave birth to the joint and the magic brownies of the 60’s. These mainstays are now being updated with vape systems and cannabis infused edible products. Similarly, the tried and true process of extracting the active marijuana oils by making cannabutter on the stove top is described. Here, the most modern approach is to now use liquefied CO₂ at 1,000 atmospheres which also dissolves oils. Reducing the pressure releases the gas leaving only the very pure cannabis extract behind.

For Mentor Capital to be featured in a main stream publication that has also featured the likes of Bacardi and McDonalds is a testament to the evolving acceptance of legalized medical marijuana and casual use across America, according to the company. With the Food & Drink writers, Mentor Capital was able to introduce the general public audience to the entrepreneurial story of Dixie Elixirs, G Farma Labs, Mountain High Products, Bhang Chocolate, Incredible Edibles, Kiva Confections, Gel-Stat and other cannabis industry leaders.

Food & Drink has a written circulation of 500,000 and the Fall 2014 “Budding Opportunities” edition is now widely available. Interested readers may also receive a free copy of the article at no charge by requesting a copy from Mentor Capital. The complete text is available at both the Mentor Capital and Food & Drink websites and at the link: http://mentorcapital.com/mentor-capital-featured-food-drink-magazine-click-view-article/

About Mentor Capital: By acquisition or stock purchase, Mentor Capital, Inc. seeks to invest in leading cannabis companies. Additional important information for investors and founders seeking expansion funding is presented at: www.MentorCapital.com

This press release is neither an offer to sell, nor a solicitation of offers to purchase, securities.

Forward Looking Statements: This press release contains forward-looking statements within the meaning of the federal securities laws, including statements concerning financial projections, financing activities, corporate combinations, product development activities and sales and licensing activities. Such forward-looking statements are not guarantees of future results or performance, are sometimes identified by words of condition such as “should,” “could,” “expects,” “may,” or “intends,” and are subject to a number of risks and uncertainties, known and unknown, that could cause actual results to differ materially from those intended or anticipated. Such risks include, without limitation: nonperformance of investments, partner and portfolio difficulties, potential delays in marketing and sales activities, problems securing the necessary financing to continue operations, problems encountered in commercializing cannabis products, potential of competitive products, services, and technologies, difficulties experienced in product development, difficulties in recruiting knowledgeable personnel and potential problems in protecting intellectual property. Further information concerning these and other risks is included in the Company’s 15c2-11 filing which, along with other very important information about the Company, can be found here: http://mentorcapital.com/disclosures/

The Company undertakes no obligation to update or revise such forward-looking statements to reflect events or circumstances occurring after the date of this press release.

(PROW) Announces Approval of U.S. Patent Claims

Mobile Broadcasting Corp.
Kenneth D. Bland
Chief Executive Officer
ken@briken.net

(ADCS) Shareholder Update

(SCOK) New Underground Coal Gasification Project $30-45 Million Expected in 2015

PINGDINGSHAN, China, Sept. 9, 2014  — SinoCoking Coal and Coke Chemical Industries, Inc. (Nasdaq:SCOK), a vertically-integrated coal and coke processor, today said it has signed an exclusive agreement with both the Institute of Process Engineering of the Chinese Academy of Sciences and the North China Institute of Science and Technology to refine and implement a technology that will be used, beginning next month, to convert the 21 million tons of coal at four SinoCoking underground mines into syngas, a clean burning fuel.

The technology will accomplish this conversion without releasing meaningful levels of carbon dioxide or other greenhouse gases above ground, said SinoCoking.

Located in Henan Province, these mines have been shut down for three years due to Chinese government-mandated mine consolidation guidelines. Now, however, these properties can be reactivated and their resources utilized in an environmentally friendly manner, said the company.

The first phase of the project, which will cost approximately $18 million and be funded primarily from SinoCoking’s cash reserves, is expected to be completed in February 2015 and yield a combined syngas output of 60,000 cubic meters per hour. This output will produce incremental gross profit in 2015 of from $30 to $45 million, said SinoCoking.

Subsequent phases of the project, expected to be completed by the end of 2016, will cost about $280 million and will be funded primarily from bank loans and company-issued debt. At completion, the project is expected to have an output capacity, subject to market demand, of 880,000 cubic meters of syngas per hour.

Customers for this syngas will be comprised primarily of local power, chemical and transportation companies as well as households requiring electricity in Henan Province, said SinoCoking.

“We are thrilled and honored to be working with the Institute of Process Engineering and North China Institute of Science and Technology on this vital project,” said SinoCoking Chairman and CEO Mr. Jianhua Lv. “The production of this vast new quantity of syngas – a clean burning fuel – while preventing the escape of carbon dioxide and other greenhouse gases, is, we believe, a major technological accomplishment.

“Combined with the opening, next month, of our above ground syngas facility in Pingdingshan, this new project further establishes our company as one of China’s leading producers of clean energy products.”

Mr. Lv said that SinoCoking would announce additional details on the construction and financing of the underground facility “in the near future.”

About SinoCoking

SinoCoking and Coke Chemical Industries, Inc. (www.scokchina.com), a Florida corporation, is a vertically-integrated coal and coke processor that uses coal from both its own mines and that of third-party mines to produce basic and value-added coal products for steel manufacturers, power generators, and various industrial users. SinoCoking has been producing metallurgical coke since 2002, and acts as a key supplier to regional steel producers in central China. SinoCoking also produces and supplies thermal coal to its customers in central China. SinoCoking currently owns its assets and conducts its operations through its subsidiaries, Top Favour Limited and PingdingshanHongyuan Energy Science and Technology Development Co., Ltd., and its affiliated companies, Henan Province PingdingshanHongli Coal & Coke Co., Ltd., Baofeng Coking Factory, BaofengHongchang Coal Co., Ltd., BaofengHongguang Environment Protection Electricity Generating Co., Ltd., Zhonghong Energy Investment Company, Henan Hongyuan Coal Seam Gas Engineering Technology Co., Ltd., BaofengShuangri Coal Mining Co., Ltd., and BaofengXingsheng Coal Mining Co., Ltd.

For further information about SinoCoking, please refer to our periodic reports filed with the Securities and Exchange Commission.

Forward Looking Statements

This press release contains forward-looking statements, particularly as related to, among other things, the business plans of the Company, statements relating to goals, plans and projections regarding the Company’s financial position and business strategy. The words or phrases “plans”, “would be,” “will allow,” “intends to,” “may result,” “are expected to,” “will continue,” “anticipates,” “expects,” “estimate,” “project,” “indicate,” “could,” “potentially,” “should,” “believe,” “think”, “considers” or similar expressions are intended to identify “forward-looking statements.” These forward-looking statements fall within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934 and are subject to the safe harbor created by these sections. Actual results could differ materially from those projected in the forward-looking statements as a result of a number of risks and uncertainties. Such forward-looking statements are based on current expectations, involve known and unknown risks, a reliance on third parties for information, transactions or orders that may be cancelled, and other factors that may cause our actual results, performance or achievements, or developments in our industry, to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from anticipated results include risks and uncertainties related to the fluctuation of local, regional, and global economic conditions, the performance of management and our employees, our ability to obtain financing, competition, general economic conditions and other factors that are detailed in our periodic reports and on documents we file from time to time with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company cautions readers not to place undue reliance on such statements. The Company does not undertake, and the Company specifically disclaims any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement. Actual results may differ materially from the Company’s expectations and estimates. The Company provides no assurances that any potential acquisitions will actually be consummated, or if consummated that such acquisitions will be on terms and conditions anticipated on the date of this press release, and the Company makes no assurances with regard to any results of any such acquisitions.

(FRHV) Announces New Business Model Focused on Enterprise and Mobile Software Applications

NEW YORK, NY / September 9, 2014 / Fresh Harvest Products, Inc. “Fresh Harvest” (OTC: FRHV) today announced the Company’s new business model to become a leading technology solutions provider focused on the development of enterprise software, software as a service (SaaS) and mobile applications for the natural food, health and wellness markets.

Fresh Harvest previously operated as a natural and organic food products company before management decided to transition the Company’s line of business to capitalize on its relationships within the rapidly growing SaaS, enterprise software and mobile application markets.

The Company expects to develop, license and acquire software applications that will generate revenue through subscription fees, in-app upgrades, purchases and advertising. Fresh Harvest plans to launch a new corporate website with information pertinent to its new business operations in the near future.

“Fresh Harvest is pleased to announce our plans to enter the cloud-based SaaS, enterprise software
and mobile app markets. In line with its new direction, the Company plans to explore several business opportunities including strategic acquisitions and the development of software and mobile applications,” commented the Company’s President and CEO, Michael J. Friedman.

“The Company expects to bring on new executives with experience and relationships that will help us succeed as a technology solutions provider as well as become current with our financials in the near future. We look forward to updating our shareholders on the Company’s progress and milestones while we aggressively ramp up business operations in our new industry,” added Mr. Friedman.

Software as a service (SaaS) is a software delivery method that provides access to software and its functions remotely as a web-based service which allows organizations to access business functionality
at a lower cost than paying for licensed applications. SaaS also eliminates hardware costs because the software is hosted remotely.

About Fresh Harvest Products, Inc.

Fresh Harvest Products, Inc. based in New York City is a technology solution provider focused on the development of enterprise software, software as a service (SaaS) and mobile applications for the health and wellness markets.

Safe Harbor Statement

This release includes forward-looking statements, which are based on certain assumptions and reflects management’s current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:
888-959-7095
ir@sealpointconsulting.com

(ALIF) Buys Back Shares

(BNNY) to be Acquired by General Mills for $46 Per Share in Cash

Companies Partnering to Accelerate the Growth and Development of the Annie’s Brand

BERKELEY, Calif., Sept. 8, 2014  — Annie’s Inc. (NYSE:BNNY) (“Annie’s”), a leading natural and organic food company, announced today a definitive agreement to be acquired by General Mills, Inc. (NYSE: GIS) (“General Mills”) for $46.00 per share in cash, for a total transaction value of approximately $820 million.  This acquisition will enable Annie’s to enter a new phase of growth and success while maximizing value for stockholders. The transaction consideration represents a 51% premium over Annie’s 30-day average closing price of $30.47 as of September 5, 2014. Annie’s will continue to be headquartered in Berkeley, California.

“We are excited about this strategic combination, which will enable Annie’s to expand the reach and breadth of our high quality, great tasting organic and natural products, provide new opportunities for our employees, realize greater efficiencies in our operations, and maximize value for our stockholders,” said John Foraker, Chief Executive Officer of Annie’s. “Powerful consumer shifts toward products with simple, organic and natural ingredients from companies that share consumers’ core values show no signs of letting up.  Partnering with a company of General Mills’ scale and resources will strengthen our position at the forefront of this trend, enabling us to more rapidly and efficiently expand into new channels and product lines in a rapidly evolving industry environment.

“Annie’s will remain dedicated to our mission: to cultivate a healthier and happier world by spreading goodness through nourishing foods, honest words and conduct that is considerate and forever kind to the planet.  Authentic roots, great tasting products, high quality organic and natural ingredients, and sustainable business practices will continue to be the cornerstones of the Annie’s brand,” concluded Foraker.

Molly Ashby, Annie’s Chairman of the Board of Directors, stated, “This transaction is a testament to the great team at Annie’s. Together, they have built a highly successful company around the authentic, mission-driven concept that Annie Withey originated 25 years ago. Annie’s is a pioneer of the new generation of company that does well by doing good, generating great value for all stakeholders. This is strategically the right time to pursue this combination because it brings operational, sourcing and distribution capabilities that enable Annie’s to build on its leadership position in the natural and organic market.”

The Annie’s Board of Directors has unanimously recommended that Annie’s stockholders accept the General Mills offer.  General Mills will launch a tender offer within ten business days to purchase all outstanding shares of Annie’s. General Mills’ offer will be subject to the tender of a majority of Annie’s shares and to certain other customary closing conditions including regulatory approval. The transaction is expected to close later in calendar 2014.

Annie’s financial advisor for the transaction is J.P. Morgan Securities LLC and its legal advisor is Proskauer Rose LLP.

About Annie’s

Annie’s, Inc. (NYSE: BNNY) is a natural and organic food company that offers great-tasting products in large packaged food categories. Annie’s products are made without artificial flavors, synthetic colors, and preservatives regularly used in many conventional packaged foods. Additionally, Annie’s sources ingredients so as to avoid synthetic growth hormones and genetically modified food ingredients. Today, Annie’s offers over 145 products and is present in over 35,000 retail locations in the United States and Canada. Founded in 1989, Annie’s is committed to operating in a socially responsible and environmentally sustainable manner. For more information, visit www.annies.com.

Forward-Looking Statements

Certain statements in this press release, including those relating to the future of our snacks business and achievement of our significant long-term growth potential, are “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by words like “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “future,” “will,” “seek” and similar terms or phrases.

The forward-looking statements contained in this press release are based on management’s current expectations, and are subject to uncertainty, changes in circumstances and significant risks. We cannot assure you that future developments affecting us will be those that we have anticipated.

Actual results may differ materially from the forward-looking statements contained in this press release due to changes in global, national, regional or local economic, business, competitive, market, regulatory and other factors, many of which are beyond our control. We believe that these factors include those disclosed in the section entitled “Risk Factors” in our Annual Report on Form 10-K for fiscal 2014 filed with the U.S. Securities and Exchange Commission (the “SEC”) on June 2, 2014 and our Form 10-Q for the quarter ended June 30, 2014 filed with the SEC on August 7, 2014, including risks relating to the occurrence of any event, change or other circumstances that could give rise to the termination of the merger agreement; the inability to complete the proposed tender offer or merger due to the failure to satisfy the conditions to completion of the tender offer and the merger; unexpected costs or unexpected liabilities that may arise from the transaction, whether or not consummated; continuation or deterioration of current market conditions; future regulatory or legislative actions that could adversely affect the companies; the outcome of any legal proceedings relating to the tender offer, the merger or the merger agreement; and risks to consummation of the merger, including the risk that the merger will not be consummated within the expected time period or at all. Additional factors that may affect future results are contained in Annie’s filings with the SEC, which are available at the SEC’s website at www.sec.gov. Annie’s disclaims any obligation to update and revise statements contained in these materials based on new information or otherwise. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, our actual results may vary in material respects from those projected in these forward-looking statements.

Notice to Investors

The tender offer described herein has not yet been commenced. The description contained herein is neither an offer to purchase nor a solicitation of an offer to sell securities of Annie’s. At the time the tender offer is commenced, General Mills and its wholly owned subsidiary intend to file a Tender Offer Statement on Schedule TO containing an offer to purchase, forms of letters of transmittal and other documents relating to the tender offer, and Annie’s intends to file a Solicitation/Recommendation Statement on Schedule 14D-9 with respect to the tender offer. General Mills, its wholly owned subsidiary and Annie’s intend to mail these documents to the stockholders of Annie’s. These documents will contain important information about the tender offer and stockholders of Annie’s are urged to read them carefully when they become available. Stockholders of Annie’s will be able to obtain a free copy of these documents (when they become available) and other documents filed by Annie’s or General Mills with the SEC at the website maintained by the SEC at www.sec.gov. In addition, the Schedule TO and related exhibits, including the offer to purchase, forms of letters of transmittal, and other related tender offer documents may be obtained (when available) for free by contacting General Mills at Number One General Mills Boulevard, Minneapolis, Minnesota 55426 and the Schedule 14D-9 may be obtained (when available) for free by contacting Annie’s at 1610 Fifth Street, Berkeley, California 94710.

CONTACT:  

Ed Aaron
510-558-7574
303-868-5551
ir@annies.com

(IPAS) to Explore Strategic Alternatives

(DGTW) to Open up Its Vast Domain Portfolio for the First Time for Leases

Moving the Portfolio From a Holding Position to a Leasing Position Creates a Recurring $4 Million Revenue Model for Growth at Maturity

(RADA) Announces Second Quarter and First Half 2014 Results

NETANYA, Israel, Sept. 8, 2014  — RADA Electronic Industries Ltd. (Nasdaq:RADA) today announced its financial results for the second quarter and the six months ended June 30, 2014.

2014 Second quarter Results

Revenues totaled $6.4 million, 23% increase compared to $5.2 million in the second quarter of 2013.

Gross Profit totaled $2.04 million, 164% increase compared to $0.8 million in the second quarter of 2013.

Operating expenses totaled $1.4 million, 11% increase compared to $1.3 million in the second quarter of 2013.

Financial Expenses totaled $262,000, 43% decrease compared to financial expenses of $459,000 in the second quarter of 2013.

As a result, the Company reported Net Income of $385,000, or $0.04 per share, for the second quarter of 2014 compared to a net loss of $935,000 or $0.10 per share, for the second quarter of 2013.

First Half 2014 Results

Revenues totaled $11.8 million, 11% increase compared to $10.6 million for the same period in 2013.

Gross profit totaled $3.7 million, 124% increase compared to $1.6 million for the same period in 2013.

Operating expenses totaled $2.6 million, 9% decrease compared to $2.8 million for the same period in 2013. 

Financial expenses totaled $555,000, 41% decrease compared to financial expenses of $934,000 for the same period in 2013.  

As a result, the Company reported Net Income of $542,000 or $0.06 per share for the six months ended June 30, 2014, compared with a net loss of $2,100,000 or $0.23 per share, for the comparable period in 2013.

Management Comment

Commenting on the results, Zvika Alon, RADA’s Chief Executive Officer said, “The increase in gross margin to approximately 32% of our total revenues, is attributable in large measure to the high margin programs that accounted for a significant portion of our revenues during this quarter. As well as the reduction in financial expenses, these two major factors generated the growth in our net profit. We have increased our marketing expenses to pursue new business, in particular in our Radars product line, which has gained operational experience in various applications during the recent Operation Protective Edge and is expected to account for a growing part of our future revenues. We expect to continue the year with similar gross margins and therefore maintain our expectation for favorable 2014 results.”

About RADA

RADA Electronic Industries Ltd. is an Israel-based defense electronics contractor. The Company specializes in the development, production, and sales of Tactical Land Radar for Force and Border Protection, Inertial Navigation Systems for air and land applications and Avionics Systems and Upgrades.

Note: Certain statements in this press release are “forward-looking statements” within the meaning of the Private Securities Litigation Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results to differ materially. Such risk uncertainties and other factors include, but are not limited to, changes in general economic conditions, risks in product and technology developments, market acceptance of new products and continuing product demand, level of competition and other factors described in the Company’s Annual Report on Form 20-F and other filings with the Securities and Exchange Commission.

CONTACT: Shiri Lazarovich- C.F.O
         RADA Electronic Industries Ltd.
         Tel: +972-9-8921111
         Shiri.Lazarovich@rada.com

(JABA) Enters Into First Contract in Sustainable Apparel

LAGUNA NIGUEL, Calif., Sept. 8, 2014  — J.D. Hutt Corporation (“JD Hutt” or the “Company”) (Pink Markets: JABA), today announced that it has entered into a contract in the sustainable apparel industry.

In May 2014, the Company announced that it had hired a new CEO, George Powell, and that its business was changing to the sustainable apparel industry. In less than three months, the Company has signed a new agreement and the apparel is already in production. The items will be delivered to the customer in early September 2014.

“We’re excited to have signed our first contract for JD Hutt,” commented George Powell. “It is with a large company and is a private-label product which will carry their brand name and logo. The customer has indicated that they have plans to move forward with a more substantial sustainable product offering in the near term. The speed with which we have signed this contract indicates the willingness of customers to engage in this new business model of sustainable apparel. Our ability to produce a wide range of sustainable and quality products is an asset to the Company’s new direction. Our customer base will expand and allow us to reach critical mass in production and revenues as we introduce sustainable products into a wide array of companies.”

The Company will be changing its name to Green Star Apparel to reflect the new line of business. The formal change will occur once all filings and approvals are completed.

About J.D. Hutt Corporation

JD Hutt’s new business focus is to enter the sustainable apparel industry in order reduce the carbon footprint and make a systemic change in how apparel is made shipped and sold. It will embrace the change and become the ecopreneurs of the industry.

Forward Looking Statements

This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. Forward-looking statements in this press release include matters that involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to differ materially from results expressed or implied by this press release. JD Hutt undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after the date of this communication except as required by law. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this communication. All forward-looking statements are qualified in their entirety by this cautionary statement.

(MCIG) Obtains Registered Trademark Approval for mCig® and VitaCig® Brands

BELLEVUE, Wash., Sept. 5, 2014  — mCig, Inc. (OTCQB:MCIG) is pleased to announce that the United States Government Patent & Trademark Office (USPTO) has officially issued the following trademarks to the company:

mCig® – Reg. No. 4591689 issued on August 26, 2014 covering electronic cigarettes, and lithium-ion batteries for electronic cigarettes.

VitaCig® – Reg. No. 4588443 issued on August 19, 2014 covering tobacco-free cigarettes and medical devices.

This marks an important milestone for the company as its intellectual property portfolio now hosts two registered trademarks providing ownership over recognizable brands covering two high-growth industries.

“We are pleased with the USPTO decision to award us the registered trademark designations for VitaCig® and mCig®. It feels great knowing that we created these brands, nurtured them, and are now the proud owners. A registered mark is an extremely valuable asset which entitles its owners to commercial ownership over a trade name. Owning the terms “VitaCig” and “mCig” within the electronic cigarette space is an accomplishment for our team and a long-term asset for shareholders.

“For a young company like ours, this development is equally important from an operations perspective. A registered mark allows us to consider other ways to monetize and grow sales. Prior to the granting of the mark, entering into any licensing deals would have been counter-productive without having ownership of our brands. We can now focus on scaling up with partners that have additional resources and capital. We are working on several of these joint ventures and look forward to updating our shareholders when they materialize,” said Paul Rosenberg.

OTCQB Directory Update – The Company has made arrangements to maintain listing on the OTCQB directory and expects to return to the directory in the coming days. Management is of the opinion that there is no discernible difference between its current status being fully reported to the Securities and Exchange Commission (SEC) or being listed on a privately owned directory of companies. In terms of graduating to a higher exchange, an OTCQB directory listing has no implications on such a move. The only requirements are regulatory (SEC) and qualitative (financials performance). We sincerely apologize to our shareholders regarding any confusion relating to this matter.

About mCig, Inc.

mCig, Inc. (OTCQB:MCIG) is a technology company focused on two long-term secular trends sweeping the globe: (1) The decriminalization and legalization of marijuana for medicinal or recreational purposes (2) The adoption of electronic vaporizing cigarettes (commonly known as “eCigs”) by the world’s 1.2 billion smokers. The company manufactures and retails the mCig® – the world’s most affordable vaporizer priced at only $10. Designed in the USA – the mCig® provides a superior smoking experience by heating plant material, waxes, and oils delivering a smoother inhalation experience. The company also owns Vapolution, Inc. which manufactures and retails home-use vaporizers such as the Vapolution 2.0. Through its wholly owned subsidiary, VitaCig, Inc. the company manufactures and retails the VitaCig®, a $5 nicotine-free eCig that delivers a water-vapor mixed with vitamins and natural flavors. See more at: http://www.mCig.org/, www.Vapolution.com, and www.VitaCig.org.

The company believes that a well regulated marijuana industry is emerging as more states follow the lead of Washington and Colorado in legalizing marijuana. A similar trend is developing within the eCig industry following the first acquisition of an electronic cigarette brand (Blucigs) by a traditional tobacco company Lorillard Inc. for $135 million followed by another acquisition in February 2014 by Altria Group Inc. of Green Smoke for $150 million. Wells Fargo analyst Bonnie Herzog estimates that eCig sales may rise from $1 Billion in 2013 to $10 billion over the next three years.

mCig, Inc. (OTCQB:MCIG) has positioned itself as a first mover at the intersection of these two trends and hopes to create shareholder value by making the mCig® one of the leading choices for electronic consumption of plant material. – See more at: http://www.mcig.org/investors/investor-opportunity-subpage/

Safe Harbor Statement

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company’s ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company’s products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company’s business, research, product development, regulatory approval, marketing and distribution plans and strategies.

CONTACT: Paul Rosenberg
         CEO
         (425) 462-4219

(PRAN) FDA Orphan Drug Designation for PBT2 for Huntington Disease

MELBOURNE, Australia, Sept. 5, 2014  — Prana Biotechnology (ASX: PBT) has today announced the US Food and Drug Administration (FDA) has granted Orphan Drug designation to PBT2 for the treatment of Huntington Disease.

Orphan drug designation is granted by the FDA to promote the development of drugs for diseases affecting less than 200,000 people in the United States. Orphan drug designation entitles Prana to seven years of market exclusivity for the use of PBT2 in the treatment of Huntington disease; protocol assistance by the FDA to optimize drug development in the preparation of a dossier that will meet regulatory requirements; and reduced fees associated with applying for market approval.

The company will also be applying for Orphan Drug designation in Europe and other jurisdictions.

Huntington disease is a neurodegenerative genetic disorder that affects muscle coordination and leads to cognitive decline and behavioral symptoms. More than 30,000 people in the US have Huntington disease and there are currently no treatments for the cognition or executive function symptoms of the disease.

Prana announced in February 2014 that its lead MPAC (Metal Protein Attenuating Compound) PBT2 had met its primary end point of safety and tolerability, and improved measures of cognitive performance – a secondary endpoint in its Reach2HD Phase 2 clinical trial involving 109 people with Huntington disease.

“The FDA’s decision to grant Orphan Drug designation is a reflection of the high unmet need for neurological drugs that can slow, halt or improve the decline of cognition and allow sufferers to have a better quality of life,” said Prana Chairman and CEO Geoffrey Kempler.

“We are very pleased to have received Orphan Drug designation from the FDA, which is a highly important input to determining the commercialisation pathway for PBT2 for the treatment of Huntington disease, and to bring to market as quickly as possible an improved treatment for people suffering from Huntington disease.”

Prana is preparing its Post Phase 2 Trial dossier for submission to the FDA to commence discussions on the next development steps for PBT2.

About Prana Biotechnology Limited

Prana Biotechnology was established to commercialise research into Alzheimer’s disease, Huntington disease and other neurodegenerative and movement disorders. The Company was incorporated in 1997 and listed on the Australian Stock Exchange in March 2000 and listed on NASDAQ in September 2002.  Researchers at prominent international institutions including The University of Melbourne, The Mental Health Research Institute (Melbourne) and Massachusetts General Hospital, a teaching hospital of Harvard Medical School, contributed to the discovery of Prana’s technology.

Forward Looking Statements

This press release contains “forward-looking statements” within the meaning of section 27A of the Securities Act of 1933 and section 21E of the Securities Exchange Act of 1934.  The Company has tried to identify such forward-looking statements by use of such words as “expects,” “intends,” “hopes,” “anticipates,” “believes,” “could,” “may,” “evidences” and “estimates,” and other similar expressions, but these words are not the exclusive means of identifying such statements.  Such statements include, but are not limited to any statements relating to the Company’s drug development program, including, but not limited to the initiation, progress and outcomes of clinical trials of the Company’s drug development program, including, but not limited to, PBT2, and any other statements that are not historical facts.  Such statements involve risks and uncertainties, including, but not limited to, those risks and uncertainties relating to the difficulties or delays in financing, development, testing, regulatory approval, production and marketing of the Company’s drug components, including, but not limited to, PBT2, the ability of the Company to procure additional future sources of financing, unexpected adverse side effects or inadequate therapeutic efficacy of the Company’s drug compounds, including, but not limited to, PBT2, that could slow or prevent products coming to market, the uncertainty of patent protection for the Company’s intellectual property or trade secrets, including, but not limited to, the intellectual property relating to PBT2, and other  risks detailed from time to time in the filings the Company makes with Securities and Exchange Commission including its annual reports on Form 20-F and its reports on Form 6-K.  Such statements are based on management’s current expectations, but actual results may differ materially due to various factions including those risks and uncertainties mentioned or referred to in this press release.  Accordingly, you should not rely on those forward-looking statements as a prediction of actual future results.

(NENE) Provides Update on SolarWindow™ Development Activities

New Energy Technologies Inc. (OTCQB:NENE), developer of see-through SolarWindow™ coatings capable of generating electricity on glass and flexible plastics announced today that the Company is successfully progressing ongoing development of its SolarWindow™ devices and modules.

“We’ve achieved significant research and development milestones, and remain sharply focused on commercializing our first-of-its-kind technology for generating electricity on glass windows,” explained Mr. John A. Conklin, President and CEO of New Energy Technologies, Inc. “We’re especially encouraged by the excellent color and transparency of our electricity-generating glass modules, and power production estimates.”

Recently, the Company’s SolarWindow™ set a new record for generating electricity while remaining see-through. New Energy engineers calculate that SolarWindow™ modules modeled for installation on a 50-story building could conservatively produce at least ten times the electrical energy of conventional rooftop photovoltaic (PV) systems and, in some instances, exceed power performance by as much as 50-fold.

Using the Company’s proprietary power production model, engineers estimate that SolarWindow™ installed on a 50-story building could generate enough electricity to power at least 100 homes while eliminating the equivalent carbon emissions produced by vehicles driving approximately 2,750,000 miles per year.

For example, SolarWindow™ modules modeling estimates for the city of Miami, Florida show SolarWindow™ modules could generate over 1.3 million kWh (kilowatt hours) of energy. Today’s rooftop systems could only generate from 28,000 to 102,000 kWh.

The Company envisions SolarWindow™ technology installations on the vast acres of tinted glass surfaces on commercial buildings, skyscrapers, and tall towers. In contrast, conventional solar power systems are limited to very small square-footage rooftops, which are already crowded with service systems. Unlike conventional solar systems, New Energy’s SolarWindow™ can be applied to all four sides of tall towers, generating electricity using natural and artificial light conditions and even shaded areas.

SolarWindow™ is currently under development for eventual commercial deployment in the estimated 80 million detached homes in America and more than five million commercial buildings. The technology is the subject of 42 patent filings, and researchers are on track to advance SolarWindow™ towards full-scale commercial manufacturability – a near-term goal.

About New Energy Technologies, Inc.

New Energy Technologies, Inc., together with its wholly owned subsidiaries, is a developer of next generation alternative and renewable energy technologies. Among the Company’s technologies under development are:

• MotionPower™ roadway systems for generating electricity by capturing the kinetic energy produced by moving vehicles – a patent-pending technology, the subject of 59 US and International patent applications. An estimated 250 million registered vehicles drive more than six billion miles on America’s roadways every day; and
• SolarWindow™ technologies, which generates electricity on see-through glass and flexible plastics with colored tints popular to skyscraper glass. Unlike conventional systems, SolarWindow™ can be applied to all four sides of tall towers, generating electricity using natural and artificial light conditions and even shaded areas. SolarWindow™ uses organic materials, which are dissolved into liquid, ideal for low-cost high-output manufacturing. New Energy’s SolarWindow™ is the subject of 42 patent applications.

Through established relationships with universities, research institutions, and commercial partners, we strive to identify technologies and business opportunities on the leading edge of renewable energy innovation. Unique to our business model is the use of established research infrastructure owned by the various institutions we deal with, saving us significant capital which would otherwise be required for such costs as land and building acquisition, equipment and capital equipment purchases, and other start-up expenses. As a result, we are able to benefit from leading-edge research while employing significantly less capital than conventional organizations.

For additional information, please call Ms. Briana L. Erickson toll-free at 1-800-213-0689 or visit: www.newenergytechnologiesinc.com.

To receive future press releases via email, please visit: http://www.newenergytechnologiesinc.com/investor_alert.

To view the full HTML text of this release, please visit: http://www.newenergytechnologiesinc.com/NENE20140508.

For media inquiries, please contact Jerry Schranz at jschranz@beckermanpr.com, or visit our Media Relations page for additional contact information: http://www.newenergytechnologiesinc.com/media_relations.

For answers to frequently asked questions, please visit our FAQs page: http://www.newenergytechnologiesinc.com/investors/faqs.

Legal Notice Regarding Forward-Looking Statements

No statement herein should be considered an offer or a solicitation of an offer for the purchase or sale of any securities. This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although New Energy Technologies, Inc. (the “Company” or “New Energy Technologies”) believes that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, it can give no assurance that such expectations and assumptions will prove to have been correct. Forward-looking statements, which involve assumptions and describe our future plans, strategies, and expectations, are generally identifiable by use of the words “may,” “will,” “should,” “could,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” or “project” or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to adverse economic conditions, intense competition, lack of meaningful research results, entry of new competitors and products, adverse federal, state and local government regulation, inadequate capital, unexpected costs and operating deficits, increases in general and administrative costs, termination of contracts or agreements, technological obsolescence of the Company’s products, technical problems with the Company’s research and products, price increases for supplies and components, litigation and administrative proceedings involving the Company, the possible acquisition of new businesses or technologies that result in operating losses or that do not perform as anticipated, unanticipated losses, the possible fluctuation and volatility of the Company’s operating results, financial condition and stock price, losses incurred in litigating and settling cases, dilution in the Company’s ownership of its business, adverse publicity and news coverage, inability to carry out research, development and commercialization plans, loss or retirement of key executives and research scientists, changes in interest rates, inflationary factors, and other specific risks. There can be no assurance that further research and development will validate and support the results of our preliminary research and studies. Further, there can be no assurance that the necessary regulatory approvals will be obtained or that New Energy Technologies, Inc. will be able to develop commercially viable products on the basis of its technologies. In addition, other factors that could cause actual results to differ materially are discussed in the Company’s most recent Form 10-Q and Form 10-K filings with the Securities and Exchange Commission. These reports and filings may be inspected and copied at the Public Reference Room maintained by the U.S. Securities & Exchange Commission at 100 F Street, N.E., Washington, D.C. 20549. You can obtain information about operation of the Public Reference Room by calling the U.S. Securities & Exchange Commission at 1-800-SEC-0330. The U.S. Securities & Exchange Commission also maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the U.S. Securities & Exchange Commission at http://www.sec.gov. The Company undertakes no obligation to publicly release the results of any revisions to these forward looking statements that may be made to reflect the events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

(UBRG) Announces NDR Energy Group Signing New Agreement to Supply Natural Gas

IRVINE, Calif., Sept. 5, 2014 — Universal Bioenergy Inc., (OTCPINK:UBRG), a publicly traded diversified energy company that markets and distributes natural gas, petroleum, coal and electricity, announced that its subsidiary NDR Energy Group signed an agreement to supply natural gas to one of the top five largest electric and gas power companies in America. The agreement is projected to generate tens of millions of dollars in additional revenue for the Company from the sales of natural gas.

Universal Bioenergy posted sales of $58.29 million for the nine months ended March 31, 2014, which was a 41.19% increase over the same period last year.

According to the utility customer, it is one of the nation’s largest producers and transporters of energy, and has a portfolio which includes thousands of megawatts of electric power generation, thousands of miles of natural gas transmission pipelines and thousands of miles of electric transmission lines. The utility serves energy customers in 10 states, and operates one of the largest natural gas storage systems in the nation, with hundreds of billions of cubic feet of storage capacity. The utility customer is traded on the New York Stock Exchange and reported over $13.12 billion in revenues in their 2013 Annual Report.

NDR Energy Group’s President and CEO, Ken Harris stated, “At the beginning of 2014, we set out on a difficult course to substantially increase our customer base. In that we already had contracts with some of the largest utilities in the US, we knew that maintaining and growing a customer base of first-in-class, large utilities would have been challenging. This new contract is with one of the five largest electric utilities in the U.S. Additionally, this new customer will be one of the most powerful energy companies concerning the natural gas trades for years to come. There are many potential future synergies concerning this transaction, including our exploration of natural gas exports. In the last six months, we have entered into contracts with two of the five largest electric utilities in the US. These continue to be exciting times for NDR.”

Universal Bioenergy is a high growth diversified energy company that is experiencing double-digit growth. NDR Energy Group, a subsidiary of Universal Bioenergy, sells natural gas to many of the largest public utilities, electric power producers and local gas distribution companies that serve millions of commercial, industrial and residential customer in the United States. The contract limits NDR Energy from disclosing the customer’s name and certain details of the transaction.

About Universal Bioenergy Inc.

Founded in 2004, Universal Bioenergy Inc., is a publicly traded independent diversified energy company that produces and markets natural gas, petroleum, coal and propane. We market energy resources to the largest public utilities, electric power producers and local gas distribution companies in the U.S., that serve millions of commercial, industrial and residential customers. We are also engaged in the acquisition and development of existing or recently discovered oil and gas fields, leases and surface coal mines. For more information visit www.universalbioenergy.com

For inquiries contact: Media Relations: Solomon Ali at 980-225-5376

Safe Harbor Statement– There are matters discussed in this media information that are forward looking statements within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. Such statements are only forecasts and actual events or results may differ materially from those discussed. For a discussion of important factors which could cause actual results to differ from the forward looking statements, refer to Universal Bioenergy Inc.’s most recent annual report and accounts and other SEC filings. The company undertakes no obligation to update publicly, or revise, forward looking statements, whether as a result of new information, future events or otherwise, except to the extent legally required.

(TXTM) New Distro Agreements w/ Prominent NY Auto Dealerships On Distracted Driving Solution

Company’s OBD-II Distracted Driving Product to Be Sold in Bright Bay Lincoln, Bright Bay Mazda of Bay Shore, NY, and Boulevard Auto World in Queens, NY